Structural and functional status of the systemic circulation arteries in patients with idiopathic pulmonary arterial hypertension with different functional abilities and endpoints

Main Article Content

I. O. Zhyvylo
G. D. Radchenko
Ye. Yu. Titov
Yu. M. Sirenko


The aim – to study the elastic properties of the systemic circulation arteries in patients with idiopathic pulmonary arterial hypertension (IPAH) with different functional abilities and endpoints.
Мaterial and methods. 152 patients were examined: 45 of them were with IPAH, 40 patients with pulmonary arterial hypertension associated with congenital heart disease, 32 patients with arterial hypertension (AH) and 35 healthy
controls. Pulse wave velocity was measured in the arteries of muscular and elastic types, also we measured cardio-ankle vascular index (CAVI).
Results. Patients with reduced (< 330 m) functional abilities (FA) compared with patients with preserved (> 330 m) FA, have significantly higher arterial stiffness: the level of right CAVI was 8.18±0.27 vs 7.02±0.23 (Р<0.005); the level of
left – 8.43±0.30 vs 7.07±0.21 (Р<0.005). Comparing groups of patients with reduced FA and with AH, CAVI measurements were higher among patients with IPAH (right side 8.18±0.27 vs 7.53±0.21, Р<0.08, left side 8.43±0.30 vs 7.39±0.20, Р<0.006). The CAVI of patients who died during the observation period was significantly higher compared to the results of surviving patients: 8.60±0.42 vs 7.01±0.20 (Р<0.001) and 8.53±0.46 vs 7.03±0.17 (Р<0.001),
Conclusions. Consequently, in addition to all known risk factors for complication and 1 year mortality among patients with IPAH, it may be possible to use CAVI as an indicator of arterial lesions of the systemic circulation.

Article Details


pulmonary arterial hypertension, elastic properties of arteries, pulse wave velocity, cardio-ankle vascular index, functional abilities, predictive markers


Сіренко Ю.М., Радченко Г.Д., Живило І.О. та ін. Досвід катетеризації правих відділів серця та легеневої артерії у хворих на легеневу гіпертензію // Серце і судини.– 2016.– № 4.– C. 23–29.

Bradley A.M., Leopold J.A. Emerging Concepts in the Mo­­­­lecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension // Circulation.– 2015.– Vol. 131.– P. 2079–2091.

Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade // J. Hypertens.– 2005.– Vol. 23 (1).– P. 9–17.

Farber H.W., Loscalzo J. Pulmonary arterial hypertension // New Engl. J. Med.– 2004.– Vol. 351.– P. 1655–1665.

Galiè N., Humbert M., Vachiery J.L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) // Eur. Heart J.– 2016.– Vol. 37 (1).– P. 67–119.

Humbert M., Morrell N.W., Archer S.L. et al. Cellular and molecular pathobiology of pulmonary arterial hypertension // J. Amer. Coll. Cardiol.– 2004.– Vol. 43.– P. 13S–24S.

Humbert M., Sitbon O., Chaouat al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era // Circulation.– 2010.– Vol. 122 (2).– P. 156–163.

Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardio­­graphy and the European Association of Cardiovascular Imaging // J. Amer. Society Echocardiography.– 2015.– Vol. 28.– P. 1–39.

McLaughlin V.V., McGoon M.D. Pulmonary arterial hypertension // Circulation.– 2006.– Vol. 114.– P. 1417–1431.

Miyamoto S., Nagaya N., Satoh T. et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing // Amer. J. Respir. Crit. Care Med.– 2000.– Vol. 161.– P. 487–492.

Rubin L.J., Badesch D.B. Evaluation and management of the patient with pulmonary arterial hypertension // Ann. Intern. Med.– 2005.– Vol. 143.– P. 282–292.

Shirai K., Utino J., Otsuka K. et al. A novel blood pressure-independent arterial wall stiffness parameter; cardioankle vascular index (CAVI) // J. Atheroscler. Thromb.– 2006.– Vol. 13.– P. 101–107.

Simonneau G., Robbins I., Beghetti al. Updated clinical classification of pulmonary hypertension // J. Am. Coll. Cardiol.– 2009.– Vol. 54.– P. S43–S54.

Versari D., Daghini E., Virdis A. et al. Endothelium-dependent contractions and endothelial dysfunction in human hypertension // British J. Pharmacology.– 2009.– Vol. 157.– P. 527–536.

Wilkinson I.B., Cockcroft J.R., Webb D.J. Pulse wave analysis and arterial stiffness // J. Cardiovasc. Pharmacol.– 1998.– Vol. 32.– P. 33–37.

Most read articles by the same author(s)

1 2 3 > >>